Drug Profile
Hib-DTaP-hepatitis B-poliovirus vaccine - Merck
Alternative Names: AR21; DTaP2-HepB-Polio-Hib - sanofi pasteur MSD; HexavacLatest Information Update: 11 Nov 2021
Price :
$50
*
At a glance
- Originator sanofi pasteur MSD
- Class Haemophilus vaccines; Hepatitis B vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 20 Sep 2005 The CHMP has recommended the suspension of Hexavac® due to concerns regarding the long-term protection against hepatitis B
- 24 Feb 2005 The CHMP is reviewing the safety of Hexavac®
- 19 Jan 2005 Aventis Pasteur MSD is now called sanofi pasteur MSD